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Abstract 
Objective: To evaluate the antibacterial activity of tea tree EO on Streptococcus 
mutans (ATCC 25175), S. salivarius (ATCC 7073) and Lactobacillus rhaminosus (ATCC 
9595). Material and Methods: The antibacterial activity of M. alternifolia EO was 
evaluated by the broth dilution method, by which minimum inhibitory and bactericidal 
concentrations (MIC and MBC) were determined. Serial dilutions range from 70243.90 
µg/mL to 26.14 µg/mL. The MIC evaluation was performed in 96-well microplates, in 
which 100 µL of Brain Heart Infusion (BHI), 100 µL of the EO dilution and 5 µL of the 
inoculum (final concentration = 5x105 CFU/mL) were inserted. After 24 h of 
incubation, MIC was determined as the lowest concentration capable of inhibiting 
microbial growth, identified by the resazurin reaction (100 µg/mL). CBM was identified 
by the absence of subculture growths (50 µL) of dilutions equal to or greater than MIC. 
Tests were performed in triplicate and at three different times (n = 9). Pharmacological 
controls (0.05% and 0.12% Chlorhexidine), growth and sterility were used to validate 
the results. Results: The MIC of M. alternifolia compared to S. mutans, S. salivarius and 
L. rhaminosus was 1940.16 µg/mL, 3977.34 µg/mL and 3977.34 µg/mL, respectively. 
The MBC values were 70243.90 µg/mL, 3977.34 µg/mL and 34265.31 µg/mL, 
respectively. Conclusion: The essential oil of M. alternifolia presented antibacterial 
activity against the microorganisms evaluated when in high concentration. 
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Introduction 
The control of the dental biofilm allows the maintenance of oral health and prevents the 
development of diseases such as caries and periodontal disease, which are strongly related to tooth 
loss [1]. Individuals who are motor deficient or are under development of this ability have difficulty 
in mechanical brushing [2]. This factor, associated with diet and the presence of cariogenic 
microbiota, alters the buccal balance [3]. 
For biofilm control in patients at risk of caries, educational and therapeutic actions such as 
supervised brushing and topical application of fluoride are particularly encouraged in communities 
with limited access to health services, but there is little scientific evidence that these interventions 
may reduce dental caries in children [4,5]. However, biologically active products are being 
incorporated into toothpastes and mouthwash solutions as supplements to traditional methods, this 
process may contribute to the cheapness and clinical efficiency of these formulations [6]. 
Natural products have demonstrated therapeutic potentials in the treatment of oral diseases 
[7]. Moreover, in relation to commercial products, they present low cost and minimize the side 
effects of conventional treatment [8]. 
The antimicrobial properties of Melaleuca essential oil alternifolia to oral biofilms have been 
reported in several studies [9-12]. In order for the product to have satisfactory antimicrobial 
activity, the Minimum Inhibitory Concentration (MIC) should be equal to or less than 100 µg/mL 
[13], however, the different commercial presentations of the natural products and the variety of 
methods to verify the antimicrobial activity make it difficult to compare of the studies [14]. 
It is important to note that in the early stages of development, the dental biofilm consists 
predominantly of oral streptococci and actinomyces, which colonize the buccal cavity in relation to 
commensalism. However, subsequent population changes lead to a higher proliferation of acidophilic 
microorganisms, such as Lactobacillus species, or Gram-negative anaerobes in the subgingival 
biofilm, which contribute to the onset and progression of dental caries and periodontal disease [15]. 
Thus, the antimicrobial control must interrupt or prevent the transition from the commensal 
to the pathogenic microbiota, allowing the microbial balance to be preserved. Therefore, the 
objective of the present study was to evaluate, in vitro, the antibacterial activity of M. alternifolia 
essential oil against strains of Streptococcus mutans, Streptococcus salivarius and Lactobacillus 
rhaminosus. 
 
Material and Methods 
General Outline of the Study 
Quantitative study with inductive approach, descriptive procedure and direct laboratory 
documentation technique [16]. 
 
Products Tested 
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The essential oil of M. alternifolia was obtained from Laszlo Aromatherapy & Aromatology® 
(Belo Horizonte, Minas Gerais, Brazil), which produces and markets on an industrial scale. The 
physico-chemical properties were described by the supplier through a technical report (Table 1). 
 
Table 1. Technical specifications by gas chromatography of the essential oil used in the 
study, supplied by the manufacturer. 
Constituent % Constituent % 
α-pinene 2.45 γ-terpinene 6.75 
cis-calamene 1.16 Terpinolene 1.25 
β-pinene 0.75 Terpinen-4-ol 50.98 
α-terpinene 11.16 α-terpineol 5.16 
Limonene 3.10 β-gurgunene 1.20 
1.8- cineol 0.70 Viridiflorene 0.84 
 
For the microdilution assay, an emulsion of the essential oil was prepared using an 
emulsifying agent (Tween 80) (Sigma-Aldrich, St. Louis, Missouri, USA). To this end, 0.8 ml of the 
essential oil, 0.05 ml of Tween 80 and 4.2 ml of sterile distilled water were added in sterile glass 
tubes. The assembly was shaken for 5 minutes in a Vortex type shaker apparatus (Mod. AP56, 
Phoenix) and the final concentration obtained was 14.4000 µg/mL (144 mg/mL) considered in this 
study the initial standard solution for the evaluated product. Dilutions were obtained according to 
the supplier's information, where the substance density was considered as 0.9 g/mL [17]. 
In order to validate the technique used in this study, pharmacological, growth and sterility 
controls, represented respectively by: chlorhexidine digluconate were reactivated in Petri dishes 
(Alamar Tecno Científica Ltda., Diadema, SP, Brazil) and incubated in an oven at 37° C for 48 hours. 
After this time, a bacterial suspension was prepared in Brain Heart Infusion (BHI) broth (HiMedia 
Laboratories®, Mumbai, India). The inoculum at the concentration of 2×107 colony forming units 
per milliliter (CFU/mL) was standardized using a spectrophotometer Orion AQ3010 (0.05% and 
0.12% CHX) (FGM Produtos Odontológicos, Joinville, SC, Brazil), developing bacterial suspension, 
and sterile culture medium. 
The reference strains used in the study were S. mutans (ATCC 25175), S. salivarius (ATCC 
7073) and L. rhaminosus (ATCC 9595). The microorganisms, maintained in culture medium with 
glycerol, Turbidity Meter (Termo Scientific) at the optical density of 0.2 to 625 nm18. 
 
Determination of Antibacterial Activity 
The antibacterial activity was determined by obtaining the Minimum Inhibitory 
Concentration (MIC) from the microdilution assay in a 96-well microtiter plate (Alamar Tecno 
Científica Ltda, Diadema, SP, Brazil) according to the M07A10 Standard of Clinical and Laboratory 
Standards Institute [18]. 
The essential oil and pharmacological controls (0.05% and 0.12% CHX) were distributed 
along columns (1 to 12) in the wells of the microtiter plate. In each of the wells, 100 µL of broth 
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(BHI) was inserted for bacterial culture. Then, 100 µl of the essential oil emulsion was added to 
obtain the initial concentration of 7.2% (70243.90 µg/mL) in the first column of the microtiter plate.  
Subsequent concentrations of the essential oil were obtained after serial dilution of the natural 
product on the microtiter plate, starting from the initial concentration of 7.2% of the marketed 
product (70243.90 µg/mL) to 0.003% (26.14 µg/mL) by transferring 100 µL of the contents to the 
subsequent well (Table 2). In the wells containing the pharmacological control, antimicrobial 
solutions were also serially diluted and, therefore, a comparative parameter for the test solution 
(Table 2). 
 
Table 2. Concentrations of tea tree essential oil (EO) and pharmacological controls (µg/mL) used in 
the antimicrobial activity assay against S. mutans, S. salivarius and L. rhaminosus [18]. 
Well Tea tree EO (µg/mL) 0.05 % Chlorhexidine (µg/mL) 0.12%  Chlorhexidine (µg/mL) 
1 70243.90 243.90 585.36 
2 34265.31 118.97 285.54 
3 16714.78 58.03 139.28 
4 8153.55 28.31 67.94 
5 3977.34 - - 
6 1940.16 - - 
7 946.42 - - 
8 461.66 - - 
9 225.2 - - 
10 109.85 - - 
11 53.58 - - 
12 26.14 - - 
 
After the dilution of the evaluated substances, 5 µL of the suspension of the microorganisms 
(2×107 CFU / mL) were inserted in all wells, except in the column corresponding to the sterility 
control. The final concentration of microorganisms per well was 5×105 CFU/mL, as established by 
Standard M07A10 [18]. 
After the incubation period (24 h at 37º C), the MIC corresponded to the lowest 
concentration of the essential oil in which bacterial growth did not occur, identified by the formation 
of microbial precipitate or turbidity in the culture medium after the incubation period. 
The MIC determination was confirmed by the addition of 10 µL resazurin (Sigma-Aldrich, 
St. Louis, Missouri, USA) (100 µg/mL). This colorimetric indicator is blue in its oxidation state and 
becomes pink when reduced by viable cells. Thus, the detection of microbial growth was confirmed 
by the reduction of resazurin salt [19]. 
After incubation for 4 h, the results were read, in which the dye was pink (viable) or blue 
(non-viable) after oxidation by cellular metabolism [20]. The wells with the highest concentration of 
tea tree essential oil and visible growth after incubation were analyzed for bacterial viability from 
subculture on BHI Agar (HiMedia Laboratories, Mumbai, India) [21]. 
The Minimum Bactericidal Concentration (MBC) was obtained by sowing 50 µL aliquots of 
dilutions equal to or greater than MIC in Petri dishes containing BHI Agar. After sowing, petri 
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dishes were incubated in a bacteriological oven at 37º C for 48h. The CBM was considered to be the 
lowest concentration of the substance in which visible growth inhibition of the subculture was 
observed or the formation of up to three Colony Forming Units (CFU) [22]. The tests for 
determination of MIC and MBC were performed in three independent experiments, each in triplicate. 
 
Statistical Analysis 
Data from the serial dilutions in which the MIC was observed were tabulated in the 
Microsoft Office Excel 2007® Program and analyzed descriptively, obtaining the fashion values. 
 
Results 
S. mutans strains (ATCC 25175), S. salivarius (ATCC 7073) and L. rhaminosus (ATCC 
9595) were found to be susceptible to the action of the tea tree essential oil, as they showed values of 
MICs below 70243.90 µg/mL (Table 3). The tea tree essential oil had lower values of MIC on S. 
mutans (1940.16 µg/mL) and lower values for CBM on S. salivarius (3977.34 µg/mL). 
 
Table 3. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) 
obtained for the tea tree essential oil (melaleuca) against test strains, in three independent 
experimental events. Values expressed in (µg/mL). 
Events 
 
Strains 
1º 2º 3º Mode 
MIC MBC MIC MBC MIC MBC MIC MBC 
S. mutans 1940.1 >70243.9 1940.1 70243.9 1940.1 70243.9 1940.1 70243.9 
S. salivarius  8153.5 8153.5 3977.3 3977.3 3977.3 3977.3 3977.3 3977.3 
L. rhaminosus 3977.3 34265.3 3977.3 16714.7 3977.3 34265.3 3977.3 34265.3  
 
The CIM and CBM of the pharmacological controls (0.05% and 0.12% CHX) demonstrated 
absence of bacterial growth at both concentrations. Sterility control and growth control showed, 
respectively, the absence of contamination of the culture medium and the viability of the strains 
tested. 
 
Discussion 
The present study used the broth dilution method, considered the most sensitive method to 
determine antimicrobial activity [23], presenting a value of 1940.16 µg/mL against S. mutans strain 
(ATCC 25175). 
Studies comparing agar and dilution techniques in broth presented statistical differences 
between these methods [23]. When evaluating the antimicrobial activity on planktonic cultures, the 
values for the MIC of the tea tree oil, using the diffusion method in agar, S. mutans (ATCC 25175) 
and S. mutans (JC-2) were found to be 1000 µg/mL [24,25]. The difference between the results 
observed in the literature [24,25] and the data from the present study are probably related to the 
method determination of antimicrobial activity. 
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Previous study have identified MIC values lower than L. rhaminosus (300 µg/mL) and 
higher for S. mutans (2500 µg/mL) [9]. Differences in MIC values can be justified by the different 
strains tested, as well as by the method of obtaining the essential oil, its seasonality, or place of 
cultivation. 
Several studies have evaluated the effect of the tea tree essential oil on bacteria of the dental 
biofilm [9,24-28], but no study included S. salivarius, making it difficult to compare the results 
found in this investigation, in which it presented 3977.34 µg/mL for MIC and MBC, and this value is 
considered high [14]. 
Although the incorporation of substances into the natural products is observed as an artifice 
of potentializing their action [29], the present study did not do this evaluation. However, the 
combination of the tea tree essential oil and chlorhexidine against S. mutans did not obtain good 
results, because when compared to the oils of cinnamon (620 µg/mL) and manuka (Leptospermum 
scoparium) (620 µg/mL), the tea tree EO (2500 µg/mL) presented the worst performance [25], 
configuring the low additive potential of this natural product. 
In previous studies, the use of tea tree essential oil as an alternative antibacterial was 
considered unfavorable. When evaluating its effect on the salivary levels of S. mutans in the 
formulation of 2% solution for mouthwash, there was no statistically significant difference between 
the groups that used Listerine and 0.12% chlorhexidine [11]. As observed in the present study, tea 
tree EO seems to demonstrate effect at high concentrations. Under the conditions of the present 
study, the MIC of tea tree EO against S. mutans equals a formulation of 0.2% (2 mg/mL). Given 
clinical use, a concentration of 10×MIC would be acceptable to demonstrate effectiveness. However, 
the same clinical study mentioned previously reported unpleasant taste (66.6%) and burning 
sensation (77.8%) [30], highlighting inconveniences of clinical use. 
Natural products must have minimum inhibitory concentrations of 100 µg/mL or less to be 
considered satisfactory [14]. Although the tea tree EO presented antimicrobial action against the 
strains evaluated, the MICs probably did not make the investigations more thorough, since the yield 
to make this product therapeutically would exceed limits of economic viability. 
Clinical studies previously conducted with this product [12,30] demonstrate some 
antimicrobial efficacy [12], but inefficiency of clinical use [30]. The MICs found in the present 
study would also exceed the limit of cytotoxicity, since the 0.2% concentration has been shown to 
have a deleterious effect on human endothelial cells [24]. The antimicrobial and therapeutic 
potential of the tea tree essential oil should be explored from the isolation of bioactive molecules 
from bioprospecting. The capacity for therapeutic use in the form of essential oil appears to be 
limited. 
 
Conclusion 
The tea tree essential oil has antibacterial activity against microorganisms evaluated in high 
concentration. The use of this product in therapeutic strategies should be considered for its 
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antimicrobial efficacy and suitability for use. Bioactive molecules appear to be part of the composition 
of this natural product. 
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